Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Elizabeth Goode MD

Elizabeth C Goode MD

Wellcome Trust Doctoral Fellow, the Wellcome Trust Sanger Institute, Cambridge; Clare College, University of Cambridge; and Senior Clinical Fellow in Transplant Hepatology, Addenbrooke’s Hospital, Cambridge, United Kingdom

Dr Goode graduated from Imperial College London in 2009, with Bachelor of Medicine, Bachelor of Surgery and 1st class intercalated Bachelor of Science degree in Medical Sciences with Haematology. Her undergraduate research, under the supervision of Professor Mike Laffan at the MRC London Institute of Medical Sciences, focused on deciphering the function of N-linked glycans on the synthesis and function of von Willebrand Factor. In 2011, she commenced an NIHR Academic Clinical Fellowship in Gastroenterology, gaining her Membership of the Royal College of Physicians shortly afterwards. She quickly developed an interest in immune-mediated liver diseases, specifically primary sclerosing cholangitis (PSC). Alongside her clinical training in Gastroenterology and Hepatology, she spent several years working with the UK-PSC Consortium, under the supervision of Dr Simon Rushbrook and Dr Gideon Hirschfield, where she developed and published the UK-PSC risk score; a clinical risk score that predicts adverse outcome in patients with PSC (

In 2016 Dr Goode was awarded a University of Cambridge Wellcome Trust Clinical PhD Fellowship and joined the Wellcome Trust Sanger Institute in Cambridge, under the supervision of Dr Carl Anderson. Here, her work has focused on furthering our understanding of genetic variants associated with PSC risk, using a combination of computational statistical and wet-lab approaches in the generation and analysis of RNA sequencing data.  Alongside this, she holds her Royal College of Physicians Specialty Certificate in Gastroenterology and continues to work as a Senior Clinical Fellow in Transplant Hepatology at Addenbrookes Hospital in Cambridge, UK.